Target intelligence / Profile preview

Actin gamma 1 pseudogene 22 (ACTG1P22)

Target: ACTG1P22
Molecular classification: Other (pseudogene)

Overview

Actin gamma 1 pseudogene 22 (ACTG1P22) is a human pseudogene, identified by sequence similarity to the functional actin gamma 1 gene (ACTG1). Pseudogenes like ACTG1P22 are generally considered non-functional genetic elements that do not produce functional protein products and are not known to play roles in therapeutic targeting, biological function, or disease. There is no evidence that ACTG1P22 is expressed or involved in disease or is relevant as a drug target[4][5].

Other names: ACTG1P22actin gamma 1 pseudogene 22

Beyond the preview

Go deeper on Actin gamma 1 pseudogene 22 (ACTG1P22).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin gamma 1 pseudogene 22 (ACTG1P22).

Explore the full profile